PSA
43
6
MO
47
6
QRVO
16
-6
HRB
40
3
AMG
33
-11
V
70
14
EXPE
83
8
UA
48
6
HUM
25
4
AIZ
61
5
EXR
42
5
MAC
53
5
BF.B
35
2
LB
16
9
TGNA
48
5
VIX
41
-11
HAS
29
3
FITB
36
3
DIS
70
2
PNC
48
6
PSA
43
6
MO
47
6
QRVO
16
-6
HRB
40
3
AMG
33
-11
V
70
14
EXPE
83
8
UA
48
6
HUM
25
4
AIZ
61
5
EXR
42
5
MAC
53
5
BF.B
35
2
LB
16
9
TGNA
48
5
VIX
41
-11
HAS
29
3
FITB
36
3
DIS
70
2
PNC
48
6
Financhill
Back

EyePoint Pharmaceuticals Stock Predictions

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
33

EYPT
EyePoint Pharmaceuticals

Last Price:
$7.12
Seasonality Move:
7.64%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

EyePoint Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 47.8% based on the past 19 years of stock performance.
  • EyePoint Pharmaceuticals has risen higher in 8 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.11%
  • Is EyePoint Pharmaceuticals Stock Undervalued?
    The current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will EyePoint Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 47.8% based on the past 19 years of stock performance.

EyePoint Pharmaceuticals Stock Rating

Sell
33
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals overpriced?

  • EyePoint Pharmaceuticals has risen higher in 8 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.11%

EyePoint Pharmaceuticals Stock Price History

Is EYPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com

52-Week Data

52-Week High:
30.99
52-Week Low:
6.90

Prediction Charts

Market Cap:
485.9M
Price in USD:
7.12
Volume:
4.2M
Beta:
1.86

Technical Analysis

SMA50:
9.70
SMA100:
9.10
SMA200:
11.63
52-Wk Change:
-63.22%

Stock Predictions

  • Is EyePoint Pharmaceuticals stock public?
    Yes, EyePoint Pharmaceuticals is a publicly traded company.
  • What is the EyePoint Pharmaceuticals stock quote today?
    The EyePoint Pharmaceuticals stock price is 7.12 USD today.
  • How to buy EyePoint Pharmaceuticals stock online?
    You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 8.64 8.37 8.88 8.34
Dec-4 8.38 8.49 8.56 8.31
Dec-5 8.43 8.16 8.55 8.10
Dec-6 8.34 8.71 8.97 8.20
Dec-9 8.84 8.85 9.23 8.82
Dec-10 8.88 8.46 9.00 8.21
Dec-11 8.50 8.25 8.50 8.03
Dec-12 8.22 7.94 8.23 7.71
Dec-13 7.90 7.46 8.07 7.44
Dec-16 7.42 7.61 7.65 7.21
Dec-17 7.65 8.02 8.21 7.54
Dec-18 8.04 7.44 8.16 7.21
Dec-19 7.54 7.12 7.54 7.04
Dec-20 6.96 7.12 7.42 6.90

EyePoint Pharmaceuticals Earnings

EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

EyePoint Pharmaceuticals Forecast Revenue Growth

EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.